Company officials cite an unfilled pipeline as an obstacle to recruitment; some observers see need for more aggressive recruiting.
TOO FEW: BIO president Carl Feldbaum cites the pipeline issue rather than discrimination as the main reason for small minority representation.
While those in the industry say the problem is quite real, it is difficult to quantify. Large and small biotechnology companies approached by The Scientist declined to provide breakdowns on the racial and ethnic makeup of their scientific staffs. And the Washington, D.C.-based Biotechnology Industry Organization (BIO),...